Literature DB >> 2959497

A new semisynthetic ergot peptide alkaloid: DCN 203-922.

R K Giger1, H R Loosli, M D Walkinshaw, B J Clark, J M Vigouret.   

Abstract

We report the synthesis, stereochemistry and preliminary pharmacological evaluation of DCN 203-922, a novel ergot alkaloid of the cyclol type, which contains in its peptide moiety the uncommon amino acid L-allo-isoleucine.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2959497     DOI： 10.1007/bf01956061

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  4 in total

1.  [The total synthesis of ergotamine].

Authors:  A HOFMANN; A J FREY; H OTT
Journal:  Experientia       Date:  1961-05-15

2.  The configuration of the alloisoleucine present in maple syrup urine disease plasma.

Authors:  B Halpern; G E Pollock
Journal:  Biochem Med       Date:  1970-11

3.  Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites.

Authors:  G Maurer; E Schreier; S Delaborde; H R Loosli; R Nufer; A P Shukla
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

4.  Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.

Authors:  J M Vigouret; H R Bürki; A L Jaton; P E Züger; D M Loew
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.